Amin Ramezani - Search Results

Year	Number of Results
2012	1
2013	4
2014	2
2015	2
2016	4
2017	3
2018	5
2019	6
2020	4
2021	5
2022	6
2023	9
2024	5

1

Metformin attenuates symptoms of osteoarthritis: role of genetic diversity of Bcl2 and CXCL16 in OA.

Alimoradi N, Tahami M, Firouzabadi N, Haem E, Ramezani A. Alimoradi N, et al. Among authors: ramezani a. Arthritis Res Ther. 2023 Mar 7;25(1):35. doi: 10.1186/s13075-023-03025-7. Arthritis Res Ther. 2023. PMID: 36879307 Free PMC article. Clinical Trial.

2

Indoleamine 2, 3-Dioxygenase: A Professional Immunomodulator and Its Potential Functions in Immune Related Diseases.

Heidari F, Ramezani A, Erfani N, Razmkhah M. Heidari F, et al. Among authors: ramezani a. Int Rev Immunol. 2022;41(3):346-363. doi: 10.1080/08830185.2020.1836176. Epub 2020 Oct 29. Int Rev Immunol. 2022. PMID: 33118843 Review.

3

A comprehensive meta-analysis of transcriptome data to identify signature genes associated with pancreatic ductal adenocarcinoma.

Kordshouli SO, Tahmasebi A, Moghadam A, Ramezani A, Niazi A. Kordshouli SO, et al. Among authors: ramezani a. PLoS One. 2024 Feb 7;19(2):e0289561. doi: 10.1371/journal.pone.0289561. eCollection 2024. PLoS One. 2024. PMID: 38324544 Free PMC article.

4

Tatibody, a recombinant antibody with higher internalization potency.

Ramezani A, Asgari A, Kaviani E, Hosseini A, Ghaderi A. Ramezani A, et al. Mol Immunol. 2021 Jul;135:320-328. doi: 10.1016/j.molimm.2021.04.027. Epub 2021 May 7. Mol Immunol. 2021. PMID: 33971510

5

Optimization of Expression and Purification of Recombinant Mouse plac1.

Rahdan S, Razavi SA, Nazari M, Shojaeian S, Shokri F, Amiri MM, Ramezani A, Zarnani AH. Rahdan S, et al. Among authors: ramezani a. Avicenna J Med Biotechnol. 2022 Jan-Mar;14(1):61-69. doi: 10.18502/ajmb.v14i1.8171. Avicenna J Med Biotechnol. 2022. PMID: 35509359 Free PMC article.

6

Anti-CD19/CD8 bispecific T cell engager for the potential treatment of B cell malignancies.

Maghsoodi N, Zareinejad M, Golestan A, Mahmoudi Maymand E, Ramezani A. Maghsoodi N, et al. Among authors: ramezani a. Cell Immunol. 2023 Nov-Dec;393-394:104787. doi: 10.1016/j.cellimm.2023.104787. Epub 2023 Nov 11. Cell Immunol. 2023. PMID: 37976975

7

Immunological mechanisms of the nucleocapsid protein in COVID-19.

Edalat F, Khakpour N, Heli H, Letafati A, Ramezani A, Hosseini SY, Moattari A. Edalat F, et al. Among authors: ramezani a. Sci Rep. 2024 Feb 14;14(1):3711. doi: 10.1038/s41598-024-53906-3. Sci Rep. 2024. PMID: 38355695 Free PMC article.

8

Association of IFITM1 Promoter Methylation with Severity of SARS-CoV-2 Infection.

Arefinia N, Yaghoubi R, Ramezani A, Farokhnia M, Zadeh AMA, Sarvari J. Arefinia N, et al. Among authors: ramezani a. Clin Lab. 2023 Apr 1;69(4). doi: 10.7754/Clin.Lab.2022.220622. Clin Lab. 2023. PMID: 37057950

9

CtNorm: Real time PCR cycle of threshold (Ct) normalization algorithm.

Ramezani A. Ramezani A. J Microbiol Methods. 2021 Aug;187:106267. doi: 10.1016/j.mimet.2021.106267. Epub 2021 Jun 8. J Microbiol Methods. 2021. PMID: 34116107

10

Production of a biosimilar version of aflibercept to improve VEGF blocker cytotoxicity on endothelial cells.

Ramezani A, Zareinejad M, Mahmoudi Maymand E, Kaviani E, Ghaderi A. Ramezani A, et al. Growth Factors. 2023 Aug;41(3):140-151. doi: 10.1080/08977194.2023.2227271. Epub 2023 Jun 28. Growth Factors. 2023. PMID: 37377438

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

55 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

55 results

Results by year